You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 

You are reading 1 of 2 free-access articles allowed for 30 days

Pharma payments to be published this afternoon

By Mindo - 30th Jun 2016 | 2 views

ToV data relates to research and development funding including clinical trials support; donations and grants to HCOs (e.g. medical equipment, education and staff etc); contributions to the cost of events (e.g. medical conferences and educational events) for HCOs and HCPs: sponsorship, registration fees and travel and accommodation costs; and fees and related expenses for services and consultancy (e.g. participation in advisory boards etc).

In 2015, the total value for R&D was €9.7 million. ToV to HCOs was €10.7 million, and for HCPs it was €6.8 million.

Details of transfers of value made in 2015 by each member company of IPHA – and some non-member companies voluntarily participating – will be available in an IPHA central report at www.transferofvalue.ie from 4pm today. Subsequent reports will be published within six months of year end and will be publicly available for three years from date of initial publication.

In order to comply with personal rights under data protection law, consent must be obtained by companies from HCPs for publication of the individual data. In the absence of consent, an aggregate value of transfers of value to non-consenting HCPs is disclosed.

Individuals may grant or withdraw their consent at any time and any change arising will be reflected in the relevant return by each company throughout the year. Such consent is not required from HCOs.

Commenting on the publication of the ToV data, IPHA CEO Mr Oliver O’Connor said: “Interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of patient treatment and the value of future research. They have delivered numerous innovative medicines and changed the way many diseases impact on our lives.

“This new level of transparency is designed to assure the public that they can trust their HCPs to recommend treatment or administer appropriate care based solely on clinical evidence. Along with the research based pharmaceutical industry across Europe, Ireland, as represented by IPHA, has today entered this new era of transparency. The commencement of disclosure, which will from now on be an annual event, is a clear demonstration of the pharmaceutical industry is committed to working with healthcare professionals and organisations to drive innovation that benefits patients.”

<em>Article updated 3.12pm</em>

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read